117 related articles for article (PubMed ID: 36007556)
21. Hyaluronan-cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery.
Tsai SW; Yu DS; Tsao SW; Hsu FY
Int J Nanomedicine; 2013; 8():2399-407. PubMed ID: 23861585
[TBL] [Abstract][Full Text] [Related]
22. Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
Sinha P; Udhumansha U; Rathnam G; Ganesh M; Jang HT
Int J Biol Macromol; 2018 Oct; 117():840-850. PubMed ID: 29807085
[TBL] [Abstract][Full Text] [Related]
23. Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers.
El-Helw AR; Fahmy UA
Int J Nanomedicine; 2015; 10():5797-804. PubMed ID: 26396513
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of statin-induced contractile dysfunction in rat cultured skeletal myofibers.
Tanaka S; Sakamoto K; Yamamoto M; Mizuno A; Ono T; Waguri S; Kimura J
J Pharmacol Sci; 2010; 114(4):454-63. PubMed ID: 21127387
[TBL] [Abstract][Full Text] [Related]
26. Maximizing the Therapeutic Efficacy of Imatinib Mesylate-Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design.
Kassem MA; El-Sawy HS; Abd-Allah FI; Abdelghany TM; El-Say KM
J Pharm Sci; 2017 Jan; 106(1):111-122. PubMed ID: 27544432
[TBL] [Abstract][Full Text] [Related]
27. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
[TBL] [Abstract][Full Text] [Related]
28. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
29. Pleiotropic Anticancer Properties of Scorpion Venom Peptides:
Mikaelian AG; Traboulay E; Zhang XM; Yeritsyan E; Pedersen PL; Ko YH; Matalka KZ
Drug Des Devel Ther; 2020; 14():881-893. PubMed ID: 32161447
[TBL] [Abstract][Full Text] [Related]
30. The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.
Thakral NK; Ray AR; Bar-Shalom D; Eriksson AH; Majumdar DK
Int J Nanomedicine; 2011; 6():1057-68. PubMed ID: 21720517
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
Kocarek TA; Reddy AB
Drug Metab Dispos; 1996 Nov; 24(11):1197-204. PubMed ID: 8937853
[TBL] [Abstract][Full Text] [Related]
32. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
[TBL] [Abstract][Full Text] [Related]
33. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
[TBL] [Abstract][Full Text] [Related]
34. Development, Statistical Optimization and Characterization of Fluvastatin Loaded Solid Lipid Nanoparticles: A 3
Asif AH; Desu PK; Alavala RR; Rao GSNK; Sreeharsha N; Meravanige G
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335960
[TBL] [Abstract][Full Text] [Related]
35. Phyto-Phospholipid Conjugated Scorpion Venom Nanovesicles as Promising Carrier That Improves Efficacy of Thymoquinone against Adenocarcinoma Human Alveolar Basal Epithelial Cells.
Asfour HZ; Fahmy UA; Alharbi WS; Almehmady AM; Alamoudi AJ; Tima S; Mansouri RA; Omar UM; Ahmed OAA; Zakai SA; Aldarmahi AA; Bagalagel A; Diri R; Alhakamy NA
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959424
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.
Suzumura K; Tanaka K; Yasuhara M; Narita H
Biol Pharm Bull; 2000 Jul; 23(7):873-8. PubMed ID: 10919369
[TBL] [Abstract][Full Text] [Related]
37. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome.
Xing L; Dawei C; Liping X; Rongqing Z
J Control Release; 2003 Dec; 93(3):293-300. PubMed ID: 14644579
[TBL] [Abstract][Full Text] [Related]
38. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Inoue M; Nakamura H
Gastroenterology; 2002 Feb; 122(2):308-17. PubMed ID: 11832446
[TBL] [Abstract][Full Text] [Related]
39. Experimental and theoretical studies on fluvastatin primary photoproduct formation.
Jarmużek D; Pedzinski T; Hoffmann M; Siodła T; Salus K; Pluskota-Karwatka D
Phys Chem Chem Phys; 2017 Aug; 19(33):21946-21954. PubMed ID: 28650504
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability.
Maeda S; Matsuoka I; Iwamoto T; Kurose H; Kimura J
Mol Pharmacol; 2005 Aug; 68(2):414-20. PubMed ID: 15879517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
